title: ABT-199 partners with azacitidine to contest myeloid malignancies.
authors.affiliation: Department of Clinical Haematology, Alfred Hospital, Australian Centre for Blood Diseases, Monash University , Melbourne , Australia.
authors.forename: Andrew
authors.initials: A
authors.lastname: Wei
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D001374:Azacitidine / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000494:pharmacology*; D006801:Humans; D009596:Nitrophenols / Q000494:pharmacology*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D009596:Nitrophenols; D013449:Sulfonamides; D001374:Azacitidine